Surface Logix surfacelogix.com


Public lists: Pharma Startups (4740)

Surface Logix with background in biophysical chemistry is developing to create new small molecule drugs.

Surface Logix with background in biophysical chemistry is developing to create new small molecule drugs.

Company (Acquired)

Phone: 617-746-8500

Fax:

50 Soldiers Field Place

Brighton, 02135
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Surface Logix $114M Jun 24, 2011
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Surface Logix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
ARCH Venture PartnersVenture CapitalChicago, Illinois, United StatesUnattributed VC, Series E, Series D, Series C
HBM Healthcare InvestmentsVenture CapitalZug, SwitzerlandUnattributed VC, Series E, Series C
CW GroupGloucestershire, United KingdomUnattributed VC, Series D, Series C
HBM PartnersPrivate EquityZug, SwitzerlandUnattributed VC, Series D, Series C
California Public Employees Retirement SystemPension FundSacramento, California, United StatesUnattributed VC, Series C
See all 15 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibitors of microsomal triglyceride transfer protein and apo-b secretion Mar 17, 2015 May 23, 2017 Patent
Rho-kinase inhibitors and method of preparation Dec 23, 2014 Sep 13, 2016 Patent
Inhibitors of microsomal triglyceride transfer protein and apo-b secretion Apr 19, 2006 Mar 17, 2015 Patent
Pharmacokinetically improved compounds Dec 14, 2012 Dec 23, 2014 Patent
Pharmacokinetically improved compounds Mar 27, 2006 Jan 22, 2013 Patent
See all 7 patents